Patent ID: 8513421

Claim:
A compound of formula (I): or a pharmaceutically acceptable salt thereof; wherein: each occurrence of R 1a is independently hydrogen, C 1-4 alkyl, or C 1-4 fluoroalkyl; each occurrence of R 1 is independently hydrogen, chloro, fluoro, —O—C 1-4 alkyl, cyano, hydroxy, C 1-4 alkyl, or C 1-4 fluoroalkyl; one of R 2a or R 2b is G and the other is R 1 ; G is —R 3 , —V 1 —R 3 , —V 1 -L 1 -R 3 , -L 1 -V 1 —R 3 , or -L 1 -R 3 ; L 1 is an unsubstituted or substituted C 1-3 alkylene chain; V 1 is —C(O)—, —C(S)—, —C(O)—CR A ═CR A —, —C(O)—N(R 4a )—, —C(O)—O—, —S(O) 2 —, —N(R 4a )—, —N(R 4a )—C(O)—, —SO 2 —N(R 4a )—, —N(R 4a )—SO 2 —, —O—, —S—, —S(O)—, —N(R 4a )—C(O)—N(R 4a )—, —N(R 4a )—C(O)—O—, —O—C(O)—N(R 4a )—, or —N(R 4a )—SO 2 —N(R 4a )—; R 3 is unsubstituted or substituted C 1-6 aliphatic; unsubstituted or substituted 3-10-membered cycloaliphatic; unsubstituted or substituted 4-10-membered heterocyclyl having 1-4 heteroatoms independently selected from nitrogen, oxygen, and sulfur; unsubstituted or substituted 6-10-membered aryl; or unsubstituted or substituted 5-10-membered heteroaryl having 1-5 heteroatoms independently selected from nitrogen, oxygen, and sulfur; each occurrence of R A is independently hydrogen, fluoro, or unsubstituted or substituted C 1-4 aliphatic; and each occurrence of R 4a is independently hydrogen, or unsubstituted or substituted C 1-4 aliphatic.